Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathespin-B

Inflammation

Volumn 21, Issue 6, 1997, Pages 609-617

  Singhal, Pravin C ^a   Reddy, Krishna ^a   Franki, Nicholas ^a   Sanwal, Vibha ^a   Gibbons, Nora ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; MESSENGER RNA; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL LABELING; CONTROLLED STUDY; DRUG EFFECT; GEL ELECTROPHORESIS; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; RAT; SPLEEN CELL;

ANIMALS; APOPTOSIS; CATHEPSIN B; MORPHINE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPLEEN;

EID: 0031457459     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027334122387     Document Type: Article

References (42)

1. LOURIA, D. B., T. HENSLE, and J. ROSE. 1957. The major medical complications of heroin addiction. Ann. Intern. Med. 67:1-22.
2. BRIGGS, J. H., C. G. MCKERRON, R. I. SOUHAMI, D. J. E. TAYLOR, and H. ANDREWS. 1967. Severe systemic infections complicating mainline heroin addiction. Lancet 2:1227-1231.
3. CHERUBIN, C. E. 1971. The medical sequelae of heroin addiction. Arch. Intern. Med. 128:309-313.
4. TUBARO, E., G. BORELLI, C. CROSE, G. CAVALLO, and C. SANTIANGELI. 1983. Effect of morphine on resistance to infection. J. Infect. Dis. 148:655-666.
5. MCDONAUGH, R. J., J. J. MADDEN, A. FALEK, D. A. SHAFER, M. PLINE, D. GORDON, P. BOKOS, J. C. KUEHNLE, and J. MENDELSON. 1980. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts. J. Immunol. 125:2539-2543.
6. BROWN, S. W., B. STIMMEL, R. N. TAUB, S. KOCHWA, and R. E. ROSENFIELD. 1974. Immunologic dysfunction in opiate addicts. Arch. Intern. Med. 134:1001.
7. WYBRAN, J., T. APPELBOOM, J. P. FAMAEY, and A. GOVAERTS. 1979. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 123:1068-1070.
8. ARORA, P. K., E. FRIDE, J. PETTITO, K. WAGGIE, and P. SKOLNICK. 1990. Morphine-induced immune alterations in vivo. Cell Immunol. 126:343-353.
9. BRYANT, H. U., E. W. BERNTON, and J. W. HOLADAY. 1987. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41:1731-1738.
10. SEI, Y., K. YOSHIMOTO, T. MCINTYRE, P. SKOLNICK, and P. K. ARORA. 1991. Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J. Immunol. 146:194-196.
11. FUCHS, B. A., and S. B. PRUETT. 1993. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Ther. 266:417-423.
12. THOMPSON, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
13. WYLLIE, A. H., J. F. R. KERR, and A. R. CURRIE. 1980. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68:251-305.
14. SAVILL, J., V. FADOK, P. HENSON, and C. HASLETT. 1993. Phagocytic recognition of cells undergoing apoptosis. Immunol. Today 14:131-136.
15. OBERHAMMER, F., P. R. WILSON, and M. SIKORSKA. 1993. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:3679-3684.
16. FLIPSKI, J., J. LEBLANC, T. YOUDALE, M. SIKORSKA, and P. R. WALKER. 1990. Periodicity of DNA folding in higher order chromatin structures. EMBO J. 9:1319-1327.
17. BROWN, D. G., X. M. SUN, and G. M. COHEN. 1993. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268:3037-3039.
18. WYLLIE, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.
19. MARTIN, S. J., and D. R. GREEN. 1995. Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349-352.
20. NICHOLSON, D. W., A. ALI, N. A. THORNBERRY, J. P. VALLIANCOURT, C. K. DING, M. GALLANT, Y. GAREAU, P. R. GRIFFIN, M. LABELLE, Y. A. LAZEBNIK, N. A. MUNDAY, S. M. RAJU, S. E. SMULSON, T. T. YAMIN, V. L. YU, and D. K. MILLER. 1995. Identification and inhibition of the ICE/ced-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
21. MICHEL, D., J. G. CHABOT, E. MOYSE, E. MOYSE, M. DANIK, and R. QUIRION. 1992. Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2), Synapse 11:105-111.
22. GUENETTE, R. S., M. MOOIBROEK, K. WONG, P. WONG, and M. TENNISWOOD. 1994. Cathepsin-B. A cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. Eur. J. Biochem. 226:311-321.
23. LIEBERTHAL, W., V. TRIACA, and J. LEVINE. 1996. Mechanism of death induced by cysplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am. J. Physiol. 270:F700-F708.
24. CHOMCZYNSKI, P., and N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidine thiocynate phenol-chloroform extraction. Anal. Biochem. 162:156-159.
25. SHAVIT, Y., A. DEPAULIS, F. C. MARTIN, G. W. TERMAN, R. P. GALE, and J. C. LIEBESKIND. 1986. Involvement of brain opiate receptors in the immune suppressive effect of morphine. Proc. Natl. Acad. Sci. U.S.A. 83:7114-7117.
26. WEBER, R. J., and A. PERT. 1989. The periaqueductal gray matter mediates opiate-induced immune suppression. Science 245:188-190.
27. HO, W. K. K., and A. LEUNG. 1979. The effect of morphine addiction on concanavalin A-mediated blastogenesis. Pharmacol. Res. Commun. 11:413-419.
28. BRYANT, H. U., E. W. BERNTON, and J. W. HOLADAY. 1987. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41:1731-1738.
29. BRYANT, H. U., E. W. BERNTON, and J. W. HOLADAY. 1988. Morphine pellet-induced immunomodulation in mice: Temporal relationship. J. Pharmacol. Exp. Ther. 245:913-920.
30. BRYANT, H. U., E. W. BERNTON, J. R. KENNER, and J. W. HOLADAY. 1991. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology 128:3253-3258.
31. BRYANT, H. U., and R. E. ROUDEBUSH. 1990. Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255:410-415.
32. WEBER, R. J., B. IKEJIRI, K. C. RICE, A. PERT, and A. A. HAGAN. 1987. Opiate receptor-mediated regulation of the immune response in vivo. NIDA Res. Monogr. 76:341-348.
33. BAYER, B. M., M. R. GASTONGUAY, and M. C. HERNANDES. 1992. Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonistic sensitivity and naltrexone reversibility. Immunopharmacology 23:117-124.
34. SEI, Y., T. MCINTYRE, E. FRIDE, K. YOSKIMOTO, P. SKOLNICK, and P. K. ARORA. 1991. Inhibition of calcium mobilization is an early event in opiate-induced immunosuppression. FASEB J. 5:2194-2199.
35. LOPHER, A., L. G. ABOOD, W. HOSS, and F. J. LIONETTI. 1980. Steroselective muscarinic acetylcholine and opiate receptors in human phagocytic leucocytes. Biochem. Pharmacol. 29:1361-1365.
36. MEHRISHI, J. N., and I. H. MILLS. 1983. Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 27:240-249.
37. MADDEN, J. J., R. M. DONAHOE, J. ZWEMER-COLLINS, D. A. SHAFER, and A. FALEK. 1987. Binding of naloxone to human T lymphocytes. Biochem. Pharmacol. 36:4103-4109.
38. OVAIDA, H., P. NITSAN, and O. ABRAMSKY. 1989. Characterization of opiate binding sites on membranes of rat lymphocytes. J. Neuroimmunol. 21:93-102.
39. OVAIDA, H., and O. ABRAMSKY. 1991. Opiate binding sites on rat lymphocytes. Prog. Neuroenodocrin. Immunol. 4:121-125.
40. RADULESCU, R. T., B. R. DECOSTA, A. E. JACOBSON, K. C. RICE, J. E. BLALOCK, and D. J. J. CARR. 1991. Biochemical and functional characterization of a μ-opioid receptor binding site on cells of the immune system. Prog. Neuroendocrin. Immunol. 4:166-179.
41. TAUB, D. D., T. K. EISENSTEIN, E. B. GELLER, M. W. ADLER, and T. J. ROGERS. 1991. Immunomodulatory activity of kappa-, mu, and delta-selective opioid agonists. Proc. Natl. Acad. Sci. U.S.A. 88:360-364.
42. ROGERS, T. J., D. D. TAUB, T. K. EISENSTEIN, E. B. GELLER, and M. W. ADLER. 1991. Immunomodulatory activity of kappa-, mu-, and delta-selective opioid compounds. NIDA Res. Monogr. 105:82-88.